BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16918290)

  • 1. Choice of screening modality in a colorectal cancer education and screening program for the uninsured.
    Sarfaty M; Feng S
    J Cancer Educ; 2006; 21(1):43-9. PubMed ID: 16918290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of colorectal cancer screening in an uninsured population.
    Sarfaty M; Feng S
    Prev Med; 2005; 41(3-4):703-6. PubMed ID: 16126268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening for colorectal cancer: a cost benefit analysis on a health prevention programme at the Boehringer Ingelheim Company].
    Schneider M; Häck HJ
    Dtsch Med Wochenschr; 2011 May; 136(20):1047-52. PubMed ID: 21560104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The case for population-based screening for colorectal cancer.
    Schoen RE
    Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of diagnostic examinations for colorectal polyps.
    Menardo G
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s273-5. PubMed ID: 15666105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Precautions for intestinal cancer in the workplace. An initiative for secondary prevention in the BASF joint-stock company].
    Webendörfer S; Messerer P; Eberle F; Zober A
    Dtsch Med Wochenschr; 2004 Feb; 129(6):239-43. PubMed ID: 14750049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable.
    Levin B; Smith RA; Feldman GE; Colditz GA; Fletcher RH; Nadel M; Rothenberger DA; Schroy PS; Vernon SW; Wender R;
    Cancer; 2002 Oct; 95(8):1618-28. PubMed ID: 12365008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is routine screening for colorectal cancer justifiable? These gastroenterologists say YES!
    Early DS; Marshall JB
    Postgrad Med; 1997 Jul; 102(1):48, 50-52. PubMed ID: 9224479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Against Colorectal Cancer in Our Neighborhoods, a Community-Based Colorectal Cancer Screening Program Targeting Low-Income Hispanics: Program Development and Costs.
    Shokar NK; Byrd T; Lairson DR; Salaiz R; Kim J; Calderon-Mora J; Nguyen N; Ortiz M
    Health Promot Pract; 2015 Sep; 16(5):656-66. PubMed ID: 25983085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs.
    Subramanian S; Tangka FK; Hoover S; Degroff A; Royalty J; Seeff LC
    Eval Program Plann; 2011 May; 34(2):147-53. PubMed ID: 21036399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
    Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
    Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
    [No Abstract]   [Full Text] [Related]  

  • 15. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [National colorectal carcinoma screening program deserves further study; a report from the Dutch Health Council].
    van Veen WA
    Ned Tijdschr Geneeskd; 2001 Aug; 145(34):1655-7. PubMed ID: 11552370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal carcinoma: is screening possible?
    Bonelli L
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s267-72. PubMed ID: 15666104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for colorectal cancer.
    Brown ML
    N Engl J Med; 1993 Oct; 329(18):1352-3. PubMed ID: 8292163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.